Filter
534
Filtered Results: 534
Text search:
immunocompromised
Featured
Recommendations
73
New Publications
93
Language
Document type
No document type
218
Guidelines
165
Studies & Reports
58
Manuals
29
Fact sheets
27
Strategic & Response Plan
16
Training Material
10
Infographics
5
Situation Updates
4
Brochures
1
Resource Platforms
1
Countries / Regions
India
33
Western and Central Europe
20
South Africa
16
Latin America and the Carribbean
13
Global
11
Kenya
10
Africa
9
Philippines
7
Middle East and North Africa
6
Nepal
5
Syria
5
Nigeria
5
West and Central Africa
5
South–East Asia Region
5
Eastern Europe
5
Ethiopia
5
Ukraine
4
Rwanda
4
Mozambique
4
Asia
4
Tanzania
4
Eastern Europe and Central Asia
4
East and Southern Africa
4
Russia
4
Malawi
3
Zimbabwe
3
Venezuela
3
Germany
3
Western Pacific Region
3
Brazil
3
Indonesia
3
Ghana
2
Chile
2
Niger
2
USA
2
Congo, Democratic Republic of
2
Argentina
2
Yemen
2
Mali
2
Zambia
2
Ecuador
2
Myanmar / Burma
2
North Macedonia
1
Colombia
1
Timor Leste/ East Timor
1
Mexico
1
El Salvador
1
Lesotho
1
Benin
1
Sierra Leone
1
Kazakhstan
1
Cameroon
1
Albania
1
Singapore
1
Laos
1
Senegal
1
Congo-Brazzaville
1
Burkina Faso
1
Afghanistan
1
Peru
1
Morocco
1
Qatar
1
Mauritania
1
Haiti
1
Cambodia
1
Dominican Republic
1
Jordan
1
Saudi Arabia
1
North America
1
France
1
Tunisia
1
United Kingdom
1
Spain
1
Belarus
1
Israel
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Lebanon
1
Bangladesh
1
Vietnam
1
Uganda
1
Nicaragua
1
Namibia
1
Egypt
1
Sudan
1
Georgia
1
Honduras
1
Chad
1
Libya
1
South Sudan
1
Iraq
1
Somalia
1
Liberia
1
Madagascar
1
Eswatini/ Swaziland
1
Cuba
1
Pakistan
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
151
Clinical Guidelines
93
Women & Child Health
18
Public Health
15
Key Resources
14
Pharmacy & Technologies
11
Capacity Building
6
Toolboxes
COVID-19
138
TB
84
HIV
36
Rapid Response
32
AMR
27
NTDs
20
Planetary Health
13
Refugee
11
Caregiver
10
Ebola
9
Pharmacy
8
Cholera
7
Natural Hazards
6
Conflict
5
Polio
5
Mental Health
4
Zika
4
Global Health Education
4
Disability
3
Health Financing Toolbox
1
Sepsis contributes significantly to preventable mortality and is the final common pathway to death for severe infectious diseases; it can also arise as a complication of injuries and non-communicable diseases.
Zoonotic tuberculosis (TB) is a form of TB in people predominantly caused by the bacterial species, Mycobacterium bovis, which belongs to the M. tuberculosis complex. The implications of zoonotic TB go beyond human health. The organism is host-adapted to cattle, where it is refer...
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness and infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-1...
Prevention, identification and management of health worker infection in the context of COVID-19
recommended
This document provides interim guidance on the prevention, identification and management of health worker infection in the context of COVID-19. It is intended for occupational health departments, infection prevention and control departments or focal points, health facility administrators and public ...
The COVID-19 pandemic’s immediate costs, measured in lives lost and damaged, have been appalling and continue to rise. In addition, its effects on individuals’ livelihoods and economies around the world have been deep and are likely to be long lasting. While saving lives was the near-exclusive f...
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...
The checklist is aligned with, and builds upon, existing COVID-19-related WHO guidelines and is structured around protective measures related to: 1) hand hygiene and respiratory etiquette; 2) physical distancing; 3) use of masks in schools; 4) environmental cleaning and ventilation; and 5) respectin...
In Control. A Practical Handbook for Professionals Working in Health Emergencies Internationally
recommended
In Control imparts knowledge, provokes reflection and triggers curiosity. The first half of the book provides an overview of the organisations, principles, frameworks and themes that every professional deploying to health emergencies should be aware of. The second half of the book provides practical...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
A practitioner’s guide to the principles of COVID-19 vaccine communications.
The factors that lead people to make choices to take vaccines are nuanced and affected by how they see the world, their perceptions of the choices people like them will make, who they trust, their perceptions of risk,...
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
Efficacy shown in clinical trials in participants who received the full series of vaccine (2 doses) ir...
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic...
